Suvretta Capital Management, LLC Decibel Therapeutics, Inc. Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.85 - $4.21 $487,660 - $1.11 Million
-263,600 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$10.56 - $19.9 $2.78 Million - $5.25 Million
263,600 New
263,600 $2.99 Million

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email